Moderna is trying to be gatekeeper for the mRNA platform for future drug development — raising monopolistic fears

A pattern familiar to Covid-19 is emerging in the battle against monkeypox, with the US and Europe grabbing scarce vaccine supplies

India claims vaccines are no longer an issue in the battle against COVID-19, but a host of developing nations would disagree

Post the Ukraine war, Russia has held back from appropriating intellectual property despite having a law to punish unfriendly countries

After facing a worldwide censure for earning disproportionately during the pandemic, pharma giant Pfizer has decided to supply its patented,...

Indian and South African interests have diverged; India is not in desperate need of vaccines anymore and doesn’t want to rock the boat

Health advocates are asking Washington to use laws that allow patent override on drugs developed with public funds

Tough new conditions emerge in the compromise deal to ease WTO intellectual property barriers related to production of COVID-19 medical tools

By using IP rights as a tool of war, Russia is taking a leaf out of the US' book to seize copyright and patents owned by 'unfriendly' countries

New Delhi has not backed its WTO proposal to suspend intellectual property rights on COVID-19 pharma products with robust action

Punching way above its weight, the tiny nation has developed five vaccines, and offers hope of vaccine equity across the world

The application for securing GI tag for Banarasi paan appears to be misplaced, and could potentially lead to controversies